Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

Medical System Network Co / Equity Bottom-Up

<ul><li>1H FY03/26 sales reached JPY63.9bn (+6.9% YoY), operating profit JPY1.3bn (+25.2% YoY), net income JPY452mn (+118.4% YoY).</li><li>Community Pharmacy Network segment sales JPY120.1bn forecasted, with segment profit JPY6.0bn, driven by network expansion and digital services.</li><li>FY03/26 forecast includes sales JPY125.5bn (+2.5% YoY), EBITDA JPY6.9bn (+4.9% YoY), net income JPY1.3bn (+3.0% YoY).</li></ul>

1H FY03/26 sales reached JPY63.9bn (+6.9% YoY), operating profit JPY1.3bn (+25.2% YoY), net income JPY452mn (+118.4% YoY).Community Pharmacy Network segment sales JPY120.1bn forecasted, with segment profit JPY6.0bn, driven by network expansion and digital services.FY03/26 forecast includes sales JPY125.5bn (+2.5% YoY), EBITDA JPY6.9bn (+4.9% YoY), net income JPY1.3bn (+3.0% YoY).

Medical System Network Co (4350 JP): 1H FY03/26 flash update

<ul><li>Q1 FY03/26 sales rose 5.7% YoY to JPY31.1bn, but net income dropped 54.1% YoY to JPY78mn.</li><li>Segment sales increased 6.5% YoY to JPY29.9bn, with segment profit rising 0.4% YoY to JPY1.1bn.</li><li>Full-year FY03/26 forecast predicts sales of JPY125.5bn and net income of JPY1.3bn, up 3.0% YoY.</li></ul>

Q1 FY03/26 sales rose 5.7% YoY to JPY31.1bn, but net income dropped 54.1% YoY to JPY78mn.Segment sales increased 6.5% YoY to JPY29.9bn, with segment profit rising 0.4% YoY to JPY1.1bn.Full-year FY03/26 forecast predicts sales of JPY125.5bn and net income of JPY1.3bn, up 3.0% YoY.

Medical System Network Co (4350 JP): Q1 FY03/26 flash update

<ul><li>FY03/25 sales increased by 6.1% YoY to JPY122.4bn, while operating profit decreased by 17.7% YoY to JPY3.2bn.</li><li>FY03/26 forecast projects sales of JPY125.5bn (+2.5% YoY) and operating profit of JPY3.4bn (+7.8% YoY).</li><li>Community Pharmacy Network segment FY03/26 targets: 12,000 network affiliates, 9,000 partner pharmacies, and 6,850 digital service adopters.</li></ul>

FY03/25 sales increased by 6.1% YoY to JPY122.4bn, while operating profit decreased by 17.7% YoY to JPY3.2bn.FY03/26 forecast projects sales of JPY125.5bn (+2.5% YoY) and operating profit of JPY3.4bn (+7.8% YoY).Community Pharmacy Network segment FY03/26 targets: 12,000 network affiliates, 9,000 partner pharmacies, and 6,850 digital service adopters.

Medical System Network Co (4350 JP): Full-year FY03/25 flash update

<ul><li>Q1 FY03/25 earnings results: Sales JPY29.4bn (+6.4% YoY), Operating profit JPY468mn (+3.8% YoY), Recurring profit JPY468mn (+14.1% YoY), Net income JPY170mn (+14.9% YoY).</li><li>Segment sales: JPY28.0bn (+6.3% YoY), Segment profit: JPY1.1bn (-1.5% YoY); driven by new stores, digital technologies, and patient follow-up.</li><li>Segment sales: JPY942mn (+17.8% YoY), Segment profit: JPY56mn (+154.5% YoY); driven by construction orders and review of advertising expenses.</li></ul>

Q1 FY03/25 earnings results: Sales JPY29.4bn (+6.4% YoY), Operating profit JPY468mn (+3.8% YoY), Recurring profit JPY468mn (+14.1% YoY), Net income JPY170mn (+14.9% YoY).Segment sales: JPY28.0bn (+6.3% YoY), Segment profit: JPY1.1bn (-1.5% YoY); driven by new stores, digital technologies, and patient follow-up.Segment sales: JPY942mn (+17.8% YoY), Segment profit: JPY56mn (+154.5% YoY); driven by construction orders and review of advertising expenses.

Medical System Network Co (4350 JP): Q1 FY03/25 flash update

<ul>
<li>
<a href="https://www.smartkarma.com/entities/medical-system-network-co" target="_blank" data-smartkarma-citation="entities:3641:1" rel="noopener">Medical System Network Co (4350 JP)</a> primarily focuses on managing dispensing pharmacies and offering pharmacy support services.</li>
<li>In FY03/23, the company reported sales of JPY109.6bn, EBITDA of JPY6.1bn, operating profit of JPY3.2bn, recurring profit of JPY3.4bn, and net income attributable to owners of the parent of JPY1.6bn.</li>
<li>Medical System Network Co., Ltd. announced a decision regarding the acquisition of treasury shares.</li>
</ul>



Medical System Network Co (4350 JP) primarily focuses on managing dispensing pharmacies and offering pharmacy support services.
In FY03/23, the company reported sales of JPY109.6bn, EBITDA of JPY6.1bn, operating profit of JPY3.2bn, recurring profit of JPY3.4bn, and net income attributable to owners of the parent of JPY1.6bn.
Medical System Network Co., Ltd. announced a decision regarding the acquisition of treasury shares.


Medical System Network (4350): Q3 FY03/24 Update

Japan

MEDICAL SYSTEM NETWORK Co., Ltd. operates drug stores.  The Company also provides networking system services used in the medical industry, which enables pharmaceutical wholesalers and pharmacies to share information such as product details, prices, and inventories.  Medical System Network also operates a network database used by pharmacies to access patients' prescriptions.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medical System Network Co (4350 JP)